Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ATHEATHE
8 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ALTERITY THERAPEUTICS LTD SPONSORED ADS

CITADEL ADVISORS LLC holds 37,597 shares of ATHE (ALTERITY THERAPEUTICS LTD SPONSORED ADS), worth $201,896 as of 2026-Q2. The position was increased (+87.3% shares).

Current Value

$201,896

Current Shares

37,597

Total Value Change

+$164,424

Total Shares Change

+19,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
37,597
+87.3%
$201,8960.0%$5.37
24
2026-Q1
Increased
20,077
+19.4%
$71,4740.0%$3.40
17
2025-Q4
Decreased
16,811
-24.1%
$51,7780.0%$3.06
0
2025-Q3
New
22,144
-
$83,4830.0%$3.94
33
2024-Q4
Exited
0
-100.0%
$00.0%$3.50
0
2024-Q3
New
11,488
-
$15,3940.0%$1.33
28
2024-Q2
Exited
0
-100.0%
$00.0%$1.81
0
2024-Q1
New
18,279
-
$37,4720.0%$2.07
31

Other major holders of ATHE: Point72 Asset Management, L.P., MORGAN STANLEY, GREENLEAF TRUST, HB Wealth Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used